A Systems View Across Time and Space
Table 2 Real-world SOM calculations for hypertension based on 2017 top ten UK drug prescriptions for hypertension
Name | Number of pills sold | % market share of top ten (SOM) |
|---|---|---|
Ramipril | 27,918,000 | 40.47 |
Lisinopril | 9,087,000 | 13.17 |
Losartan potassium | 9,447,000 | 13.70 |
Candesartan Cilexetil | 6,738,000 | 9.77 |
Doxazosin Mesilate | 6,519,000 | 9.45 |
Perindopril Erbumine | 4,701,000 | 6.81 |
Irbesartan | 1,911,000 | 2.77 |
Enalapril Maleate | 1,756,000 | 2.55 |
Olmesartan Medoxomil | 474,000 | 0.69 |
Moxonidine | 430,000 | 0.62 |
Total | 68,981,000 | 100 |